logo Creation made simple
Beautifully designed
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut convallis tempor orci vitae vehicula. Aliquam in ullamcorper lacus.
Follow & share
Search:
Infallible Pharma | NIFROM INJECTION
21152
portfolio_page-template-default,single,single-portfolio_page,postid-21152,edgt-core-1.0.1,ajax_fade,page_not_loaded,,hudson-ver-1.8, vertical_menu_with_scroll,smooth_scroll,side_menu_slide_from_right,blog_installed,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

NIFROM INJECTION

NIFROM INJECTION


Brand Name : Nifrom


Generic Name : Cefuroxime sodium injection IP


Pack Size : Vial + WFI


Dosage Form : Powder for Injection


Strength : 750 mg & 1.5 gm


Therapeutic indications : Cefuroxime sodium for injection is indicated for the treatment of infections listed below in adults and children, including neonates (from birth).
Community acquired pneumonia
Acute exacerbations of chronic bronchitis
Complicated urinary tract infections, including pyelonephritis
Soft-tissue infections: cellulitis, erysipelas and wound infections
Intra-abdominal infections
Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and
gynaecological surgery (including caesarean section)
In the treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered,
cefuroxime should be administered with additional appropriate antibacterial agents.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.


Pharmacotherapeutic group : antibacterials for systemic use, Second-generation cephalosporins


ATC code : J01DC02


Pharmacodynamic properties : Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.

Date

February 18, 2022

Share